BR112013014575A2 - uso in vitro ou ex vivo, uso cosmético, processo, processo cosmético, peptídeo isolado, composição e modelo de pele in vitro ou ex vivo multicelular - Google Patents
uso in vitro ou ex vivo, uso cosmético, processo, processo cosmético, peptídeo isolado, composição e modelo de pele in vitro ou ex vivo multicelularInfo
- Publication number
- BR112013014575A2 BR112013014575A2 BR112013014575-7A BR112013014575A BR112013014575A2 BR 112013014575 A2 BR112013014575 A2 BR 112013014575A2 BR 112013014575 A BR112013014575 A BR 112013014575A BR 112013014575 A2 BR112013014575 A2 BR 112013014575A2
- Authority
- BR
- Brazil
- Prior art keywords
- vitro
- vivo
- cosmetic
- multicellular
- model
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1060429 | 2010-12-13 | ||
| FR1060429A FR2968560A1 (fr) | 2010-12-13 | 2010-12-13 | Utilisation de l'ide comme biomarqueur d'un etat du cuir chevelu |
| PCT/IB2011/055600 WO2012080929A2 (fr) | 2010-12-13 | 2011-12-12 | Utilisation de l'ide comme biomarqueur d'un etat du cuir chevelu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013014575A2 true BR112013014575A2 (pt) | 2018-03-20 |
| BR112013014575B1 BR112013014575B1 (pt) | 2022-05-31 |
Family
ID=44454113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013014575-7A BR112013014575B1 (pt) | 2010-12-13 | 2011-12-12 | Uso in vitro ou ex vivo, processo in vitro ou ex vivo e processo cosmético in vitro ou ex vivo |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10351838B2 (pt) |
| EP (1) | EP2652512B1 (pt) |
| KR (1) | KR101967489B1 (pt) |
| CN (1) | CN103384830B (pt) |
| BR (1) | BR112013014575B1 (pt) |
| ES (1) | ES2671226T3 (pt) |
| FR (1) | FR2968560A1 (pt) |
| WO (1) | WO2012080929A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2972326B1 (en) * | 2013-03-15 | 2020-01-08 | The Procter and Gamble Company | A noninvasive method for measuring metabolites for skin health |
| FR3070494B1 (fr) * | 2017-08-23 | 2022-07-01 | Oreal | Methode de diagnostic d'une peau presentant des signes de vieillissement |
| JP6703218B1 (ja) * | 2019-03-28 | 2020-06-03 | 株式会社ファンケル | 皮膚の状態を評価する方法 |
| CN112020642A (zh) * | 2019-03-28 | 2020-12-01 | 株式会社芳珂 | 评价皮肤状态的方法 |
| US11741523B2 (en) | 2019-07-31 | 2023-08-29 | L'oreal | Personalized skincare recommendations based on biomarker analysis |
| US11501356B2 (en) | 2019-07-31 | 2022-11-15 | L'oreal | Systems and methods for generating personalized skincare formulations based on biomarker analysis |
| JP7467594B2 (ja) * | 2019-07-31 | 2024-04-15 | ロレアル | パーソナライズスキンケアのためにバイオマーカー解析を使用するためのシステムおよび方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166845A (en) * | 1970-11-16 | 1979-09-04 | Colgate-Palmolive Company | Antidandruff shampoo compositions containing an aminopolyureylene resin |
| US4053630A (en) * | 1976-07-07 | 1977-10-11 | Yu Ruey J | Treatment of body odor and disturbed keratinization |
| FR2667778B1 (fr) * | 1990-10-16 | 1995-05-12 | Oreal | Cellule permettant de collecter sur la peau, par circulation de liquide, au moins un compose a doser. |
| AU6054800A (en) * | 1999-06-25 | 2001-01-31 | Arch Chemicals, Inc. | Pyrithione biocides enhanced by silver, copper, or zinc ions |
| JP3966819B2 (ja) * | 2001-05-24 | 2007-08-29 | キム，スーギョン | 毛嚢に存在する新規の第２ケラチノサイト成長因子類似体 |
| CN1555272A (zh) * | 2001-07-31 | 2004-12-15 | �ո��� | 调节免疫应答的组合物和方法 |
| CA3081228C (en) * | 2001-09-10 | 2022-02-15 | Meso Scale Technologies, Llc | Assay buffer, compositions containing the same, and methods of using the same |
| KR100564386B1 (ko) * | 2002-05-13 | 2006-03-27 | 주식회사 마이코플러스 | 4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물 |
| DK1526178T3 (da) * | 2003-10-24 | 2010-01-18 | Pasteur Institut | MSP-3-lignende genfamilie |
| DK1577320T3 (da) * | 2004-03-19 | 2012-10-15 | Pasteur Institut | Peptider afledt fra humant BPLP-protein, polynukleotider kodende for nævnte peptider og antistoffer rettet mod nævnte peptider |
| JP4892483B2 (ja) * | 2004-12-29 | 2012-03-07 | 株式会社アールテック・ウエノ | 頭皮および毛髪の処置のための組成物および方法 |
| EP2012829A4 (en) * | 2006-04-24 | 2010-04-21 | Protelix Inc | PROCESS FOR PRODUCING VIRAL VACCINE AND THERAPEUTIC PEPTIDE ANTIGENS |
| EP2052088A2 (en) * | 2006-08-02 | 2009-04-29 | Genizon Biosciences | Genemap of the human genes associated with psoriasis |
| AU2007284651B2 (en) * | 2006-08-09 | 2014-03-20 | Institute For Systems Biology | Organ-specific proteins and methods of their use |
| WO2008156701A2 (en) * | 2007-06-13 | 2008-12-24 | The Brigham And Women's Hospital, Inc. | Hydroxamate inhibitors of insulin-degrading enzyme and uses thereof |
| CA2715960A1 (en) * | 2007-12-27 | 2009-07-09 | F. Hoffmann-La Roche Ag | Insulin-degrading enzyme crystals |
| US20100209427A1 (en) * | 2008-09-24 | 2010-08-19 | Yu Li | Lysine acetylation sites |
| US8946165B2 (en) * | 2008-09-29 | 2015-02-03 | The Regents Of The University Of California | Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| US20100173428A1 (en) * | 2009-01-07 | 2010-07-08 | Ailan Guo | Protein Phosphorylation By Basophillic Serine/Threonine Kinases |
-
2010
- 2010-12-13 FR FR1060429A patent/FR2968560A1/fr active Pending
-
2011
- 2011-12-12 CN CN201180067387.7A patent/CN103384830B/zh active Active
- 2011-12-12 EP EP11805225.7A patent/EP2652512B1/fr active Active
- 2011-12-12 KR KR1020137018176A patent/KR101967489B1/ko active IP Right Grant
- 2011-12-12 US US13/993,907 patent/US10351838B2/en active Active
- 2011-12-12 WO PCT/IB2011/055600 patent/WO2012080929A2/fr active Application Filing
- 2011-12-12 ES ES11805225.7T patent/ES2671226T3/es active Active
- 2011-12-12 BR BR112013014575-7A patent/BR112013014575B1/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012080929A3 (fr) | 2012-11-01 |
| EP2652512A2 (fr) | 2013-10-23 |
| KR101967489B1 (ko) | 2019-04-09 |
| BR112013014575B1 (pt) | 2022-05-31 |
| WO2012080929A2 (fr) | 2012-06-21 |
| CN103384830B (zh) | 2017-05-24 |
| US20130337085A1 (en) | 2013-12-19 |
| EP2652512B1 (fr) | 2018-03-14 |
| CN103384830A (zh) | 2013-11-06 |
| FR2968560A1 (fr) | 2012-06-15 |
| ES2671226T3 (es) | 2018-06-05 |
| US10351838B2 (en) | 2019-07-16 |
| KR20130135887A (ko) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013014575A2 (pt) | uso in vitro ou ex vivo, uso cosmético, processo, processo cosmético, peptídeo isolado, composição e modelo de pele in vitro ou ex vivo multicelular | |
| ES2330291B1 (es) | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
| WO2011007337A3 (en) | Cosmetic use of lacritin-type polypeptides | |
| MX348078B (es) | Metodos para disminuir la produccion de sebo en la piel. | |
| CL2007001488A1 (es) | Anticuerpo humano o humanizado anti-integrina alfa5beta1; acido nucleico que lo codifica; vector y celula huesped que lo comprenden; procedimiento de produccion; composicion farmaceutica que lo comprende; y su uso para prevenir o tratar trastornos asociados con la integrina. | |
| MX358978B (es) | Exopolisacarido para el tratamiento y/o cuidado de piel, mucosas, cabello y/o uñas. | |
| WO2012116081A3 (en) | Methods for identifying cosmetic agents for skin care compositions | |
| WO2011150133A3 (en) | Fibronectin based scaffold proteins having improved stability | |
| BR112013004914A2 (pt) | "composições de pele e métodos de uso das mesmas". | |
| CY1121368T1 (el) | Αντισωματα anti-asic1 και χρησεις αυτων | |
| WO2012046084A3 (en) | Short rna molecules | |
| BR112013003522A8 (pt) | "polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, uso, método de preparação, bem como ácido nucleico codificando os mesmos" | |
| WO2012076985A3 (en) | Granzyme b inhibitor compositions, methods and uses for promoting wound healing | |
| BR112013011845A8 (pt) | enxaguatório bucal compreendendo aminoácido básico e conservante e uso cosmético do enxaguatório bucal | |
| WO2013184908A3 (en) | Systems and methods for identifying cosmetic agents for hair/scalp care compositions | |
| BR112013009083A2 (pt) | anticorpos humanos de oncostatin m e métodos de uso | |
| BR112013003530A2 (pt) | ''produto farmacêutico, kit, uso e preparações'' | |
| WO2012116990A3 (en) | Novel use | |
| WO2017151860A8 (en) | Human kynureninase enzyme variants having improved pharmacological properties | |
| BR112019004023A2 (pt) | hidrolisado de proteína, método para preparar o hidrolisado de proteína, uso dos hidrolisados de proteína, e, composições cosméticas. | |
| WO2010117709A3 (en) | Peptide-based systems for delivery of costmetic agents | |
| BR112012022037A2 (pt) | composição cosmética, processo de tratamento cosmético, uso de uma composição cosmética e uso de uma combinação | |
| BR112013012390A8 (pt) | Hidrolisado de proteína hidrofobizada | |
| FR2984735B1 (fr) | Composition hydratante | |
| BR112015006272A2 (pt) | ''uso cosmético, composto, composição cosmética e método de tratamento cosmético'' |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/12/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |